Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 8/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3850953 | 0.91 | ALDH1A1 (0.31) | ALDH1A1CA2 | |
| SCHEMBL3847679 | 0.85 | — | — | |
| SCHEMBL3845842 | 0.80 | PLAU (0.34) | — | |
| SCHEMBL591209 | 0.77 | — | — | |
| SCHEMBL8650057 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CA2GPR84SOAT1SMN1; SMN2 | |
| SCHEMBL16976528 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CA2GPR84SOAT1SMN1; SMN2 | |
| SCHEMBL8650052 | 0.73 | ALDH1A1 (0.40) | ALDH1A1CA2GPR84SOAT1SMN1; SMN2 | |
| SCHEMBL14691442 | 0.72 | MAPT (0.35) | ALDH1A1PTGS2 | |
| SCHEMBL3462780 | 0.72 | MAPT (0.35) | ALDH1A1PTGS2 | |
| SCHEMBL1164387 | 0.72 | MAPT (0.35) | ALDH1A1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109970768-B | Based on carbazole eleven-membered condensed ring planar nucleus D (A-Ar)2Organic photoelectric compound, preparation method and application | 常州大学 | 2020-12-25 | — | — | CN | disclosed |
| US-20090137789-A1 | Oligonucleotide Probes | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2009-05-28 | — | — | US | disclosed |
| EP-1819719-A2 | OLIGONUCLEOTIDE PROBES | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006051397-A2 | OLIGONUCLEOTIDE PROBES | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137789-A1 | Oligonucleotide Probes | NCL, RNGTT, NSUN3 | ALDH1A1 2227/4885CA2 3390/4885GPR84 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.